Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

106 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The systemic and hepatic alternative renin-angiotensin system is activated in liver cirrhosis, linked to endothelial dysfunction and inflammation.
Hartl L, Rumpf B, Domenig O, Simbrunner B, Paternostro R, Jachs M, Poglitsch M, Marculescu R, Trauner M, Reindl-Schwaighofer R, Hecking M, Mandorfer M, Reiberger T. Hartl L, et al. Among authors: poglitsch m. Sci Rep. 2023 Jan 18;13(1):953. doi: 10.1038/s41598-023-28239-2. Sci Rep. 2023. PMID: 36653504 Free PMC article.
Reply: RAS Fingerprint.
Poglitsch M, Basu R, Oudit GY. Poglitsch M, et al. J Am Coll Cardiol. 2017 Jun 20;69(24):3011-3013. doi: 10.1016/j.jacc.2017.03.603. J Am Coll Cardiol. 2017. PMID: 28619205 Free article. No abstract available.
Sirolimus in renal transplant recipients with tuberous sclerosis complex: clinical effectiveness and implications for innate immunity.
Haidinger M, Hecking M, Weichhart T, Poglitsch M, Enkner W, Vonbank K, Prayer D, Geusau A, Oberbauer R, Zlabinger GJ, Soleiman A, Hörl WH, Säemann MD. Haidinger M, et al. Among authors: poglitsch m. Transpl Int. 2010 Aug;23(8):777-85. doi: 10.1111/j.1432-2277.2009.01041.x. Epub 2010 Jan 11. Transpl Int. 2010. PMID: 20070623 Free article.
Optimum AT1 receptor-neprilysin inhibition has superior cardioprotective effects compared with AT1 receptor blockade alone in hypertensive rats.
Roksnoer LC, van Veghel R, de Vries R, Garrelds IM, Bhaggoe UM, Friesema EC, Leijten FP, Poglitsch M, Domenig O, Clahsen-van Groningen MC, Hoorn EJ, Jan Danser AH, Batenburg WW. Roksnoer LC, et al. Among authors: poglitsch m. Kidney Int. 2015 Jul;88(1):109-20. doi: 10.1038/ki.2015.107. Epub 2015 Apr 1. Kidney Int. 2015. PMID: 25830765 Free article.
Neprilysin is a Mediator of Alternative Renin-Angiotensin-System Activation in the Murine and Human Kidney.
Domenig O, Manzel A, Grobe N, Königshausen E, Kaltenecker CC, Kovarik JJ, Stegbauer J, Gurley SB, van Oyen D, Antlanger M, Bader M, Motta-Santos D, Santos RA, Elased KM, Säemann MD, Linker RA, Poglitsch M. Domenig O, et al. Among authors: poglitsch m. Sci Rep. 2016 Sep 21;6:33678. doi: 10.1038/srep33678. Sci Rep. 2016. PMID: 27649628 Free PMC article.
106 results